HCP (NYSE: HCP) reported Q3 FFO of $0.79, $0.02 better than the analyst estimate of $0.77. Revenue for the quarter came in at $657.95 million versus the consensus estimate of $599.42 million.

For earnings history and earnings-related data on HCP (HCP) click here.